Quanta Inc (fka QNTA)

[Dragon Lady]

QNTA_CHIEF_SCIENCE_OFFICER = TOP_SHELF_HOLY_COW :)

This dude- he's got the credentials and street cred !

NO WONDER they have high confidence of Dominican PRODUCT REGISTRATION (like FDA approval for all of Latin America) and are "at ease" working with the USA FDA and IND process- look at this dudes pedigree:

https://ir.quantrx.com/company-information/management-team

QUOTE:

"Khalid Matalka, Ph.D., SI(ASCP)
Chief Scientific Officer

Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992.

After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI-ASCP) and a member at the American Society for Cancer Research since 1994.

Dr. Matalka enrolled in academia as an assistant professor in 1995, then promoted to associate and then a professor in 2004. Prof. Matalka held a dean position at two different academic institutions. Besides, Prof. Matalka was a consultant for twenty years to a JPM pharmaceutical company and a hospital diagnostic laboratory.

During those 22 years, Prof. Matalka was heavily involved in research mainly on immunomodulation, cancer research, and development of immunological assays. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, MA as a Chief Biologist.

While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma. In March 2020, Prof. Matalka joined Medolife Corporation as Chief Scientific Officer (CSO) and, in February 2021, became the CSO of the newly established Medolife Rx.

Prof. Matalka has 65 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals.

Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
"

NIiiiiiice and WOW !!

FDA is going to sit-up and take this dude seriously when HE SUBMITS and SIGNS THEIR IND APPLICATIONS and CLINICAL DATA REPORTS etc !

HARVARD MED - among other top shelf name droppers and 65 PEER REVIEW journal pubs = BIG HITTER TERRITORY !!